Background illustration for clinical trials search

Paid Clinical Trials Nevada

Discover 491 paid clinical trials in Nevada. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase 1, Recruiting
Active & Responsive

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

for
Overweight, Obesity
Location: New Bedford MA, Needham MA, Stamford CT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07589608

Phase 2, Recruiting
Active & Responsive

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

for
Asthma
Location: Boston MA, Quebec, New York NY, Saint-Laurent, Doral FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07219173

Phase 2, Recruiting
Active & Responsive

A Study to Learn More About the Safety of a Single Dose of BIIB144 and How it is Processed in the Body of Healthy Adult Participants Ages 18 to 55 Years Old as Compared to a Placebo

for
Healthy Volunteer
Location: Las Vegas NV
Sponsor: Biogen

Sex: All

Age: 18 - 55

Code: NCT07662148

Phase 1, Recruiting
Active & Responsive

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

for
Obesity, Overweight
Location: East Greenwich RI, Waterbury CT, Chicoutimi,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07684235

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

for
Non-segmental Vitiligo
Location: The Bronx NY, Quebec, Norfolk VA, Rockville MD,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07431177

Phase 2, Recruiting
Active & Responsive

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

for
Pulmonary Hypertension, Interstitial Lung Disease (ILD)
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT06911632

Recruiting
Active & Responsive

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

for
Migraine
Location: Hyde Park MA, Providence RI, Manhasset NY, New York NY,
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70

Code: NCT06972056

Phase 4, Recruiting
Active & Responsive

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

for
Depressive Disorder, Major
Location: Boston MA, Watertown MA, Foxborough MA, Levis,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07412756

Phase 3, Recruiting
Active & Responsive

Study of DONQ52 in Active Celiac Disease

for
Celiac Disease
Location: Portland ME, Boston MA, Providence RI, Stamford CT,
Sponsor: Chugai Pharmaceutical

Sex: All

Age: 18 - 70+

Code: NCT07239336

Phase 2, Recruiting
Active & Responsive

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

for
Cardiovascular Disease
Location: Boston MA, East Greenwich RI, Hamden CT, Sherbrooke,
Sponsor: Amgen

Sex: All

Age: 50 - 70+

Code: NCT07136012

Phase 3, Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase 3, Recruiting
Active & Responsive

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: New Haven CT, Long Island City NY, New York NY,
Sponsor: Zucara Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT05762107

Phase 2, Recruiting
Active & Responsive

Helix Research Network

for
Genetic Predisposition to Disease, Genetics Disease
Location: Bethlehem PA, York PA, Rochester NY, Raleigh NC,
Sponsor: Helix, Inc

Sex: All

Age: 18+

Code: NCT06057181

Recruiting
Active & Responsive

Renal Pelvic Denervation Pilot Trial

for
Uncontrolled Hypertension
Location: Birmingham AL, Springfield IL, Iowa City IA,
Sponsor: Verve Medical, Inc

Sex: All

Age: 21 - 70+

Code: NCT07005050

Recruiting
Active & Responsive

52-week Open Label Safety-Tolerability Study

for
Schizophrenia
Location: New York NY, Philadelphia PA, Gaithersburg MD,
Sponsor: LB Pharmaceuticals Inc.

Sex: All

Age: 18 - 65

Code: NCT07369154

Phase 3, Recruiting
Active & Responsive

Post-Market Study to Assess iTind Safety in Comparison to UroLift

for
Benign Prostatic Hyperplasia (BPH)
Location: Syosset NY, Alexandria VA, Germantown TN, Omaha NE,
Sponsor: Olympus Corporation of the Americas

Sex: Male

Age: 50+

Code: NCT04757116

Recruiting
Active & Responsive

Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation

for
Capsular Contracture Associated With Breast Implant,
Location: West Long Branch NJ, New York NY, Miami FL, Orlando FL,
Sponsor: C. R. Bard

Sex: Female

Age: 22 - 70

Code: NCT05945329

Recruiting
Active & Responsive

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

for
Obesity or Overweight
Location: New York NY, Morehead City NC, Wilmington NC,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07575399

Phase 3, Recruiting
Active & Responsive

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

for
Coronavirus Disease (COVID-19)
Location: The Bronx NY, New York NY, Teaneck NJ, Newark NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06667700

Phase 3, Recruiting

Popular cities in Nevada

HendersonLas VegasReno